| Year |
Citation |
Score |
| 2020 |
Hjorth S, Waters S, Waters N, Tedroff J, Svensson P, Fagerberg A, Edling M, Svanberg B, Ljung E, Gunnergren J, McLean SL, Grayson B, Idris NF, Neill JC, Sonesson C. . The Journal of Pharmacology and Experimental Therapeutics. PMID 32605972 DOI: 10.1124/jpet.120.000037 |
0.38 |
|
| 2020 |
Waters S, Sonesson C, Svensson P, Tedroff J, Carta M, Ljung E, Gunnergren J, Edling M, Svanberg B, Fagerberg A, Kullingsjo J, Hjorth S, Waters N. Preclinical pharmacology of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine (IRL790), a novel dopamine transmission modulator for the treatment of motor and psychiatric complications in Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics. PMID 32358046 DOI: 10.1124/Jpet.119.264226 |
0.503 |
|
| 2020 |
Jansson-Löfmark R, Hjorth S, Gabrielsson J. Does in vitro potency predict clinical efficacious concentrations? Clinical Pharmacology and Therapeutics. PMID 32275768 DOI: 10.1002/cpt.1846 |
0.303 |
|
| 2016 |
Hjorth S. Looking back (and in)to the future: A personal reflection on 'Serotonin autoreceptor function and antidepressant drug action' (Hjorth et al., 2000). Journal of Psychopharmacology (Oxford, England). PMID 27166363 DOI: 10.1177/0269881116647621 |
0.402 |
|
| 2015 |
Walsh SK, Hepburn CY, Keown O, Åstrand A, Lindblom A, Ryberg E, Hjorth S, Leslie SJ, Greasley PJ, Wainwright CL. Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach. Pharmacology Research & Perspectives. 3: e00143. PMID 26236485 DOI: 10.1002/prp2.143 |
0.426 |
|
| 2015 |
Hjorth S, Karlsson C, Jucaite A, Varnäs K, Wählby Hamrén U, Johnström P, Gulyás B, Donohue SR, Pike VW, Halldin C, Farde L. A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates. Neuropharmacology. PMID 25791528 DOI: 10.1016/J.Neuropharm.2015.03.002 |
0.406 |
|
| 2015 |
Karlsson C, Hjorth S, Karpefors M, Hansson GI, Carlsson B. Baseline anandamide levels and body weight impact the weight loss effect of CB1 receptor antagonism in male rats. Endocrinology. 156: 1237-41. PMID 25549047 DOI: 10.1210/en.2014-1730 |
0.319 |
|
| 2014 |
Skowronski AA, Morabito MV, Mueller BR, Lee S, Hjorth S, Lehmann A, Watanabe K, Zeltser LM, Ravussin Y, Rosenbaum M, LeDuc CA, Leibel RL. Effects of a novel MC4R agonist on maintenance of reduced body weight in diet-induced obese mice. Obesity (Silver Spring, Md.). 22: 1287-95. PMID 24318934 DOI: 10.1002/Oby.20678 |
0.325 |
|
| 2011 |
Wennerberg M, Cheng L, Hjorth S, Clapham JC, Balendran A, Vauquelin G. Binding properties of antagonists to cannabinoid receptors in intact cells. Fundamental & Clinical Pharmacology. 25: 200-10. PMID 20608998 DOI: 10.1111/j.1472-8206.2010.00843.x |
0.337 |
|
| 2010 |
Boström J, Olsson RI, Tholander J, Greasley PJ, Ryberg E, Nordberg H, Hjorth S, Cheng L. Novel thioamide derivatives as neutral CB1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 479-82. PMID 20005704 DOI: 10.1016/j.bmcl.2009.11.125 |
0.371 |
|
| 2005 |
Ryberg E, Vu HK, Larsson N, Groblewski T, Hjorth S, Elebring T, Sjögren S, Greasley PJ. Identification and characterisation of a novel splice variant of the human CB1 receptor. Febs Letters. 579: 259-64. PMID 15620723 DOI: 10.1016/j.febslet.2004.11.085 |
0.38 |
|
| 2003 |
Felton TM, Kang TB, Hjorth S, Auerbach SB. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Naunyn-Schmiedeberg's Archives of Pharmacology. 367: 297-305. PMID 12644903 DOI: 10.1007/S00210-002-0688-X |
0.46 |
|
| 2001 |
Wikell C, Kugelberg FC, Hjorth S, Apelqvist G, Bengtsson F. Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy. Clinical Neuropharmacology. 24: 324-33. PMID 11801807 DOI: 10.1097/00002826-200111000-00003 |
0.355 |
|
| 2001 |
Wikell C, Hjorth S, Apelqvist G, Kullingsjö J, Lundmark J, Bergqvist PB, Bengtsson F. Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings. Naunyn-Schmiedeberg's Archives of Pharmacology. 363: 448-55. PMID 11330339 DOI: 10.1007/s002100100405 |
0.314 |
|
| 2000 |
Apelqvist G, Wikell C, Carlsson B, Hjorth S, Bergqvist PB, Ahlner J, Bengtsson F. Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy. Clinical Neuropharmacology. 23: 304-17. PMID 11575864 DOI: 10.1097/00002826-200011000-00003 |
0.433 |
|
| 2000 |
Bengtsson HJ, Kele J, Johansson J, Hjorth S. Interaction of the antidepressant mirtazapine with alpha2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 362: 406-12. PMID 11111835 DOI: 10.1007/s002100000294 |
0.43 |
|
| 2000 |
Hjorth S, Bengtsson HJ, Kullberg A, Carlzon D, Peilot H, Auerbach SB. Serotonin autoreceptor function and antidepressant drug action. Journal of Psychopharmacology (Oxford, England). 14: 177-85. PMID 10890313 DOI: 10.1177/026988110001400208 |
0.453 |
|
| 1999 |
Hjorth S, Auerbach SB. Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor. Brain Research. 835: 224-8. PMID 10415377 DOI: 10.1016/S0006-8993(99)01585-1 |
0.471 |
|
| 1998 |
Martin P, Carlsson ML, Hjorth S. Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats. Neuroreport. 9: 2985-8. PMID 9804302 DOI: 10.1097/00001756-199809140-00012 |
0.476 |
|
| 1998 |
Bengtsson HJ, Kullberg A, Millan MJ, Hjorth S. The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the modulation of 5-HT release--III. Clozapine and the novel putative antipsychotic S 16924. Neuropharmacology. 37: 349-56. PMID 9681933 DOI: 10.1016/S0028-3908(98)00017-3 |
0.489 |
|
| 1998 |
Hjorth S, Kullberg A, Millan MJ, Bengtsson HJ. α1-Adrenoceptor/5-hydroxytryptamine (5-HT(1A)) autoreceptor mediation of the 5-HT release-reducing action of clozapine and S16924 in rat ventral hippocampus Nordic Journal of Psychiatry. 52: 126-127. |
0.334 |
|
| 1997 |
Bergqvist PB, Wikell C, Hjorth S, Apelqvist G, Bengtsson F. Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy: implications for thymoleptic drug safety in liver insufficiency. Clinical Neuropharmacology. 20: 511-22. PMID 9403225 DOI: 10.1097/00002826-199712000-00003 |
0.449 |
|
| 1997 |
Bergqvist PB, Hjorth S, Wikell C, Apelqvist G, Bengtsson F. p-Chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy. Metabolic Brain Disease. 12: 229-36. PMID 9346471 DOI: 10.1023/B:MEBR.0000007103.82267.06 |
0.442 |
|
| 1997 |
Bergqvist PB, Hjorth S, Apelqvist G, Bengtsson F. Potassium-evoked neuronal release of serotonin in experimental chronic portal-systemic encephalopathy. Metabolic Brain Disease. 12: 193-202. PMID 9346468 DOI: 10.1023/B:MEBR.0000007100.04521.6e |
0.445 |
|
| 1997 |
Gundlah C, Hjorth S, Auerbach SB. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Neuropharmacology. 36: 475-82. PMID 9225272 DOI: 10.1016/S0028-3908(97)00052-X |
0.391 |
|
| 1997 |
Hjorth S, Westlin D, Bengtsson HJ. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor. Neuropharmacology. 36: 461-5. PMID 9225270 DOI: 10.1016/S0028-3908(97)00050-6 |
0.388 |
|
| 1997 |
Millan MJ, Hjorth S, Samanin R, Schreiber R, Jaffard R, De Ladonchamps B, Veiga S, Goument B, Peglion JL, Spedding M, Brocco M. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. The Journal of Pharmacology and Experimental Therapeutics. 282: 148-61. PMID 9223550 |
0.349 |
|
| 1997 |
Bergqvist PBF, Wikell C, Hjorth S, Apelqvist G, Bengtsson F. Citalopram and release of brain 5-HT in experimental chronic hepatic encephalopathy Biological Psychiatry. 42. DOI: 10.1016/S0006-3223(97)87873-0 |
0.372 |
|
| 1997 |
Bergqvist PBF, Hjorth S, Wikell C, Apelqvist G, Bengtsson F. P-chloroamphetamine- and D-fenfluramine-induced brain 5-HT release in chronic hepatic encephalopathy Biological Psychiatry. 42. DOI: 10.1016/S0006-3223(97)87541-5 |
0.373 |
|
| 1996 |
Bergqvist PB, Hjorth S, Audet RM, Apelqvist G, Bengtsson F, Butterworth RF. Ammonium acetate challenge in experimental chronic hepatic encephalopathy induces a transient increase of brain 5-HT release in vivo. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 6: 317-22. PMID 8985716 DOI: 10.1016/S0924-977X(96)00037-5 |
0.444 |
|
| 1996 |
Hjorth S, Bengtsson HJ, Milano S. Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo. European Journal of Pharmacology. 316: 43-7. PMID 8982649 DOI: 10.1016/S0014-2999(96)00779-0 |
0.451 |
|
| 1996 |
Sharp T, Umbers V, Hjorth S. The role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--II NAN-190 and SDZ 216-525. Neuropharmacology. 35: 735-41. PMID 8887982 DOI: 10.1016/0028-3908(96)84645-4 |
0.364 |
|
| 1996 |
Bergqvist PB, Hjorth S, Apelqvist G, Bengtsson F. Acute effects of L-tryptophan on brain extracellular 5-HT and 5-HIAA levels in chronic experimental portal-systemic encephalopathy. Metabolic Brain Disease. 11: 269-78. PMID 8869946 DOI: 10.1007/Bf02237963 |
0.447 |
|
| 1996 |
Hjorth S. (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. European Journal of Pharmacology. 303: 183-6. PMID 8813565 DOI: 10.1016/0014-2999(96)00185-9 |
0.464 |
|
| 1996 |
Hjorth S, Auerbach SB. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI). Behavioural Brain Research. 73: 281-3. PMID 8788519 DOI: 10.1016/0166-4328(96)00113-1 |
0.38 |
|
| 1996 |
Hedberg MH, Linnanen T, Jansen JM, Nordvall G, Hjorth S, Unelius L, Johansson AM. 11-substituted (R)-aporphines: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions. Journal of Medicinal Chemistry. 39: 3503-13. PMID 8784448 DOI: 10.1021/jm960189i |
0.458 |
|
| 1996 |
Hedberg MH, Jansen JM, Nordvall G, Hjorth S, Unelius L, Johansson AM. 10-substituted 11-oxygenated (R)-aporphines: synthesis, pharmacology, and modeling of 5-HT1A receptor interactions. Journal of Medicinal Chemistry. 39: 3491-502. PMID 8784447 DOI: 10.1021/jm960188q |
0.473 |
|
| 1996 |
Vallgårda J, Appelberg U, Arvidsson LE, Hjorth S, Svensson BE, Hacksell U. trans-2-Aryl-N,N-dipropylcyclopropylamines: synthesis and interactions with 5-HT(1A) receptors. Journal of Medicinal Chemistry. 39: 1485-93. PMID 8691479 DOI: 10.1021/jm9507136 |
0.463 |
|
| 1995 |
Auerbach SB, Hjorth S. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 352: 597-606. PMID 9053730 DOI: 10.1007/Bf00171317 |
0.51 |
|
| 1995 |
Hedberg MH, Johansson AM, Nordvall G, Yliniemelä A, Li HB, Martin AR, Hjorth S, Unelius L, Sundell S, Hacksell U. (R)-11-hydroxy- and (R)-11-hydroxy-10-methylaporphine: synthesis, pharmacology, and modeling of D2A and 5-HT1A receptor interactions. Journal of Medicinal Chemistry. 38: 647-58. PMID 7861413 DOI: 10.1021/Jm00004A011 |
0.488 |
|
| 1995 |
Hjorth S, Suchowski CS, Galloway MP. Evidence for 5-HT autoreceptor-mediated, nerve impulse-independent, control of 5-HT synthesis in the rat brain. Synapse (New York, N.Y.). 19: 170-6. PMID 7784957 DOI: 10.1002/syn.890190304 |
0.668 |
|
| 1995 |
Zhang J, Engel JA, Hjorth S, Svensson L. Changes in the acoustic startle response and prepulse inhibition of acoustic startle in rats after local injection of pertussis toxin into the ventral tegmental area. Psychopharmacology. 119: 71-8. PMID 7675952 DOI: 10.1007/BF02246056 |
0.637 |
|
| 1995 |
Auerbach SB, Lundberg JF, Hjorth S. Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration. Neuropharmacology. 34: 89-96. PMID 7623967 DOI: 10.1016/0028-3908(94)00137-H |
0.455 |
|
| 1995 |
Hjorth S, Bengtsson HJ, Milano S, Lundberg JF, Sharp T. Studies on the role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--I. BMY7378 and prazosin. Neuropharmacology. 34: 615-20. PMID 7566497 DOI: 10.1016/0028-3908(95)00038-8 |
0.488 |
|
| 1995 |
Bergqvist PB, Vogels BA, Bosman DK, Maas MA, Hjorth S, Chamuleau RA, Bengtsson F. Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt. Journal of Neurochemistry. 64: 1238-44. PMID 7532208 DOI: 10.1046/J.1471-4159.1995.64031238.X |
0.465 |
|
| 1994 |
Hjorth S, Auerbach SB. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. European Journal of Pharmacology. 260: 251-5. PMID 7988652 DOI: 10.1016/0014-2999(94)90346-8 |
0.477 |
|
| 1994 |
Hjorth S, Auerbach SB. Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology. 33: 331-4. PMID 7984270 DOI: 10.1016/0028-3908(94)90062-0 |
0.37 |
|
| 1994 |
McRae A, Ling EA, Hjorth S, Dahlström A, Mason D, Tice T. Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats. Molecular Neurobiology. 9: 191-205. PMID 7888096 DOI: 10.1007/BF02816119 |
0.378 |
|
| 1994 |
Hoffmann P, Elam M, Thorén P, Hjorth S. Effects of long-lasting voluntary running on the cerebral levels of dopamine, serotonin and their metabolites in the spontaneously hypertensive rat. Life Sciences. 54: 855-61. PMID 7511199 DOI: 10.1016/0024-3205(94)00622-9 |
0.366 |
|
| 1993 |
Hjorth S. Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. Journal of Neurochemistry. 60: 776-9. PMID 8419553 DOI: 10.1111/J.1471-4159.1993.Tb03217.X |
0.446 |
|
| 1993 |
Galloway MP, Suchowski CS, Keegan MJ, Hjorth S. Local infusion of the selective 5HT-1b agonist CP-93,129 facilitates striatal dopamine release in vivo. Synapse (New York, N.Y.). 15: 90-2. PMID 8310427 DOI: 10.1002/syn.890150109 |
0.692 |
|
| 1993 |
Hjorth S, Sharp T. In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. The Journal of Pharmacology and Experimental Therapeutics. 265: 707-12. PMID 8098761 |
0.397 |
|
| 1993 |
Sharp T, McQuade R, Bramwell S, Hjorth S. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 348: 339-46. PMID 7904048 DOI: 10.1007/Bf00171331 |
0.379 |
|
| 1993 |
Söderpalm B, Lundin B, Hjorth S. Sustained 5-hydroxytryptamine release-inhibitory and anxiolytic-like action of the partial 5-HT1A receptor agonist, buspirone, after prolonged chronic administration. European Journal of Pharmacology. 239: 69-73. PMID 7901030 DOI: 10.1016/0014-2999(93)90977-P |
0.419 |
|
| 1993 |
Hjorth S, Pettersson G. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo. European Journal of Pharmacology. 238: 357-67. PMID 7691622 DOI: 10.1016/0014-2999(93)90867-H |
0.509 |
|
| 1993 |
Höök BB, Johansson AM, Hjorth S, Sundell S, Hacksell U. Synthesis of (+)-(R)- and (-)-(S)-5-hydroxy-2-methyl-2-dipropylaminotetralin: effects on rat hippocampal output of 5-HT, 5-HIAA, and DOPAC as determined by in vivo microdialysis. Chirality. 5: 112-9. PMID 7687852 DOI: 10.1002/chir.530050303 |
0.416 |
|
| 1993 |
Andersson B, Wikström H, Hjorth S, Svensson K, Carlsson A, Sundell S, Lundmark M, Largent B. Resolved 2-arylcyclohexylamines: Effects on reserpine akinesia and central nervous system monoamine synthesis European Journal of Medicinal Chemistry. 28: 63-69. DOI: 10.1016/0223-5234(93)90079-T |
0.51 |
|
| 1992 |
Hjorth S. Acute reserpine treatment increases rat brain serotonin synthesis via a nerve impulse-dependent mechanism. Journal of Neurochemistry. 58: 772-5. PMID 1530868 DOI: 10.1111/J.1471-4159.1992.Tb09785.X |
0.473 |
|
| 1992 |
Hjorth S. (-)-Penbutolol as a blocker of central 5-HT1A receptor-mediated responses. European Journal of Pharmacology. 222: 121-7. PMID 1468487 DOI: 10.1016/0014-2999(92)90471-F |
0.533 |
|
| 1992 |
Tao R, Hjorth S. Differences in the in vitro and in vivo 5-hydroxytryptamine extraction performance among three common microdialysis membranes. Journal of Neurochemistry. 59: 1778-85. PMID 1383427 DOI: 10.1111/j.1471-4159.1992.tb11010.x |
0.392 |
|
| 1992 |
Nissbrandt H, Hjorth S. Dopaminergic neurotransmission in somatodendritic and terminal areas of the rat brain: susceptibility to modulation by D1 and D2 receptors and to axotomy. Journal of Neural Transmission. General Section. 90: 13-26. PMID 1361343 DOI: 10.1007/BF01250514 |
0.398 |
|
| 1992 |
McRae A, Hjorth S, Dahlström A, Dillon L, Mason D, Tice T. Dopamine fiber growth induction by implantation of synthetic dopamine-containing microspheres in rats with experimental hemi-parkinsonism. Molecular and Chemical Neuropathology / Sponsored by the International Society For Neurochemistry and the World Federation of Neurology and Research Groups On Neurochemistry and Cerebrospinal Fluid. 16: 123-41. PMID 1355653 DOI: 10.1007/BF03159965 |
0.436 |
|
| 1992 |
Tao R, Hjorth S. Alpha 2-adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 345: 137-43. PMID 1349158 DOI: 10.1007/BF00165728 |
0.448 |
|
| 1992 |
Nissbrandt H, Waters N, Hjorth S. The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 346: 12-9. PMID 1328893 DOI: 10.1007/BF00167564 |
0.603 |
|
| 1991 |
Hjorth S. Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists. European Journal of Pharmacology. 199: 237-42. PMID 1835441 DOI: 10.1016/0014-2999(91)90463-Z |
0.541 |
|
| 1991 |
Hjorth S, Sharp T. Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sciences. 48: 1779-86. PMID 1826937 DOI: 10.1016/0024-3205(91)90216-X |
0.463 |
|
| 1991 |
Hjorth S, Tao R. The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. European Journal of Pharmacology. 209: 249-52. PMID 1797566 DOI: 10.1016/0014-2999(91)90177-R |
0.515 |
|
| 1991 |
Ahlenius S, Hillegaart V, Hjorth S, Larsson K. Effects of sexual interactions on the in vivo rate of monoamine synthesis in forebrain regions of the male rat. Behavioural Brain Research. 46: 117-22. PMID 1786120 DOI: 10.1016/S0166-4328(05)80104-4 |
0.378 |
|
| 1991 |
McRae A, Hjorth S, Mason DW, Dillon L, Tice TR. Microencapsulated dopamine (DA)-induced restitution of function in 6-OHDA-denervated rat striatum in vivo: comparison between two microsphere excipients. Journal of Neural Transplantation & Plasticity. 2: 165-73. PMID 1782252 DOI: 10.1155/NP.1991.165 |
0.416 |
|
| 1990 |
McRae A, Hjorth S, Mason D, Dillon L, Tice T. Implantable microencapsulated dopamine (DA): prolonged functional release of DA in denervated striatal tissue. Journal of Neural Transmission. Supplementum. 29: 207-15. PMID 2358802 DOI: 10.1007/978-3-7091-9050-0_20 |
0.394 |
|
| 1990 |
Hjorth S, Sharp T. Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies. Life Sciences. 46: 955-63. PMID 2329921 DOI: 10.1016/0024-3205(90)90097-B |
0.531 |
|
| 1990 |
Sharp T, Hjorth S. Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor. Journal of Neuroscience Methods. 34: 83-90. PMID 2259248 DOI: 10.1016/0165-0270(90)90045-H |
0.507 |
|
| 1990 |
Hillegaart V, Hjorth S, Ahlenius S. Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat. Journal of Neural Transmission. General Section. 81: 131-45. PMID 2141990 DOI: 10.1007/BF01245833 |
0.472 |
|
| 1990 |
Sharp T, Backus LI, Hjorth S, Bramwell SR, Grahame-Smith DG. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378. European Journal of Pharmacology. 176: 331-40. PMID 1970304 DOI: 10.1016/0014-2999(90)90027-4 |
0.401 |
|
| 1990 |
Gartside SE, Cowen PJ, Hjorth S. Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo. European Journal of Pharmacology. 191: 391-400. PMID 1964908 DOI: 10.1016/0014-2999(90)94173-U |
0.555 |
|
| 1990 |
Hjorth S, Sharp T, Liu Y. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study. Naunyn-Schmiedeberg's Archives of Pharmacology. 341: 149-57. PMID 1692973 DOI: 10.1007/Bf00169724 |
0.505 |
|
| 1990 |
Hacksell U, Arvidsson LE, Johansson AM, Karlén A, Luthman K, Hjorth S. Stereoselectivity of Drug Receptor Interactions Drug Information Journal. 24: 485-496. DOI: 10.1177/009286159002400306 |
0.472 |
|
| 1989 |
Sharp T, Bramwell SR, Hjorth S, Grahame-Smith DG. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. British Journal of Pharmacology. 98: 989-97. PMID 2574066 DOI: 10.1111/J.1476-5381.1989.Tb14630.X |
0.417 |
|
| 1989 |
Söderpalm B, Hjorth S, Engel JA. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test. Pharmacology, Biochemistry, and Behavior. 32: 259-65. PMID 2567524 DOI: 10.1016/0091-3057(89)90242-6 |
0.583 |
|
| 1989 |
Nissbrandt H, Sundström E, Jonsson G, Hjorth S, Carlsson A. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum. Journal of Neurochemistry. 52: 1170-82. PMID 2564423 DOI: 10.1111/J.1471-4159.1989.Tb01863.X |
0.615 |
|
| 1989 |
Hjorth S, Sharp T, Hacksell U. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3. European Journal of Pharmacology. 170: 269-74. PMID 2533557 DOI: 10.1016/0014-2999(89)90549-9 |
0.503 |
|
| 1989 |
Hillegaart V, Hjorth S. Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity. European Journal of Pharmacology. 160: 303-7. PMID 2527161 DOI: 10.1016/0014-2999(89)90505-0 |
0.485 |
|
| 1988 |
Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Lindberg P, Andersson B. N,N-Dialkylated monophenolic trans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonists. Journal of Medicinal Chemistry. 31: 92-9. PMID 3336037 |
0.588 |
|
| 1988 |
Hjorth S, Clark D, Carlsson A. Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation. European Journal of Pharmacology. 152: 207-15. PMID 3146512 DOI: 10.1016/0014-2999(88)90715-7 |
0.676 |
|
| 1988 |
McRae-Degueurce A, Hjorth S, Dillon DL, Mason DW, Tice TR. Implantable microencapsulated dopamine (DA): a new approach for slow-release DA delivery into brain tissue. Neuroscience Letters. 92: 303-9. PMID 3143953 DOI: 10.1016/0304-3940(88)90607-6 |
0.369 |
|
| 1988 |
Hajos M, Hjorth S, Svensson K, Carlsson A. In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion. Experimental Brain Research. 70: 577-84. PMID 3133239 DOI: 10.1007/BF00247605 |
0.607 |
|
| 1988 |
Hjorth S, Carlsson A. In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390. Journal of Neural Transmission. 72: 83-97. PMID 2968439 DOI: 10.1007/BF01250232 |
0.61 |
|
| 1988 |
White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacology, Biochemistry, and Behavior. 30: 189-93. PMID 2902644 DOI: 10.1016/0091-3057(88)90442-X |
0.376 |
|
| 1988 |
Hjorth S, Magnusson T. The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 338: 463-71. PMID 2469021 DOI: 10.1007/BF00179315 |
0.388 |
|
| 1987 |
Johansson AM, Nilsson JL, Karlén A, Hacksell U, Sanchez D, Svensson K, Hjorth S, Carlsson A, Sundell S, Kenne L. C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors. Journal of Medicinal Chemistry. 30: 1827-37. PMID 3656358 DOI: 10.1021/JM00393A025 |
0.58 |
|
| 1987 |
Ahlenius S, Carlsson A, Hillegaart V, Hjorth S, Larsson K. Region-selective activation of brain monoamine synthesis by sexual activity in the male rat. European Journal of Pharmacology. 144: 77-82. PMID 3436362 DOI: 10.1016/0014-2999(87)90011-2 |
0.562 |
|
| 1987 |
Hjorth S, Carlsson A, Engel JA. Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm. Psychopharmacology. 92: 371-5. PMID 3114790 DOI: 10.1007/BF00210846 |
0.682 |
|
| 1987 |
Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Andersson B, Wikström H. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist. Journal of Medicinal Chemistry. 30: 2105-9. PMID 2959776 DOI: 10.1021/Jm00394A029 |
0.656 |
|
| 1987 |
Fernández-Guasti A, Ahlenius S, Hjorth S, Larsson K. Separation of dopaminergic and serotonergic inhibitory mechanisms in the mediation of estrogen-induced lordosis behaviour in the rat. Pharmacology, Biochemistry, and Behavior. 27: 93-8. PMID 2956611 DOI: 10.1016/0091-3057(87)90482-5 |
0.553 |
|
| 1987 |
Hjorth S, Carlsson A. Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393. Psychopharmacology. 93: 534-7. PMID 2893419 DOI: 10.1007/BF00207249 |
0.606 |
|
| 1987 |
Hjorth S, Söderpalm B, Engel JA. Biphasic effect of L-5-HTP in the Vogel conflict model. Psychopharmacology. 92: 96-9. PMID 2885883 DOI: 10.1007/BF00215486 |
0.549 |
|
| 1987 |
Hajós M, Hjorth S, Carlsson A. Injection of capsaicin into the nucleus raphe dorsalis elicits heat loss in the rat. Neuroscience Letters. 75: 199-204. PMID 2437500 DOI: 10.1016/0304-3940(87)90297-7 |
0.503 |
|
| 1986 |
Svensson K, Carlsson M, Carlsson A, Hjorth S, Johansson AM, Eriksson E. The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats. European Journal of Pharmacology. 130: 237-42. PMID 3792447 DOI: 10.1016/0014-2999(86)90273-6 |
0.702 |
|
| 1986 |
Hjorth S, Svensson K, Carlsson A, Wikström H, Andersson B. Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP. Naunyn-Schmiedeberg's Archives of Pharmacology. 333: 205-18. PMID 3762735 DOI: 10.1007/Bf00512931 |
0.647 |
|
| 1986 |
Hjorth S, Eriksson E, Andersson B. Stereoselective inhibition of prolactin secretion by (-)-HW-165, a novel 3-PPP congener; further support for similarities between central DA autoreceptors and pituitary lactotroph DA receptors. European Journal of Pharmacology. 125: 421-8. PMID 3755402 DOI: 10.1016/0014-2999(86)90798-3 |
0.568 |
|
| 1986 |
Svensson K, Hjorth S, Clark D, Carlsson A, Wikström H, Andersson B, Sanchez D, Johansson AM, Arvidsson LE, Hacksell U. (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors. Journal of Neural Transmission. 65: 1-27. PMID 3083041 DOI: 10.1007/BF01249608 |
0.656 |
|
| 1986 |
Hjorth S, Engel JA, Carlsson A. Anticonflict effects of low doses of the dopamine agonist apomorphine in the rat. Pharmacology, Biochemistry, and Behavior. 24: 237-40. PMID 3006085 DOI: 10.1016/0091-3057(86)90344-8 |
0.696 |
|
| 1986 |
Ahlenius S, Fernandez-Guasti A, Hjorth S, Larsson K. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat. European Journal of Pharmacology. 124: 361-3. PMID 2942412 DOI: 10.1016/0014-2999(86)90241-4 |
0.519 |
|
| 1986 |
Hjorth S, Carlsson A. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? European Journal of Pharmacology. 129: 131-8. PMID 2429847 DOI: 10.1016/0014-2999(86)90344-4 |
0.648 |
|
| 1985 |
Hjorth S, Carlsson A, Clark D, Svensson K, Sanchez D. Dopamine receptor-mediated hypothermia induced in rats by (+)-, but not by (-)-3-PPP. European Journal of Pharmacology. 107: 299-304. PMID 3979430 DOI: 10.1016/0014-2999(85)90254-7 |
0.717 |
|
| 1985 |
Wikström H, Andersson B, Sanchez D, Lindberg P, Arvidsson LE, Johansson AM, Nilsson JL, Svensson K, Hjorth S, Carlsson A. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists. Journal of Medicinal Chemistry. 28: 215-25. PMID 3968686 DOI: 10.1021/Jm00380A012 |
0.653 |
|
| 1985 |
Hjorth S, Clark D, Svensson K, Carlsson A, Thorberg O. Sub-chronic administration of (-)-3-PPP and central dopamine receptor sensitivity changes. Journal of Neural Transmission. 64: 187-98. PMID 3936899 DOI: 10.1007/Bf01256466 |
0.597 |
|
| 1985 |
Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Clark D, Carlsson A, Sanchez D, Andersson B. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors. Journal of Medicinal Chemistry. 28: 1049-53. PMID 3927002 |
0.484 |
|
| 1985 |
Clark D, Hjorth S, Carlsson A. Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence. Journal of Neural Transmission. 62: 1-52. PMID 3894582 DOI: 10.1007/Bf01260414 |
0.682 |
|
| 1985 |
Hjorth S, Carlsson A. (-)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis. Neuropharmacology. 24: 1143-6. PMID 2867485 DOI: 10.1016/0028-3908(85)90207-2 |
0.577 |
|
| 1985 |
Clark D, Hjorth S, Carlsson A. Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. Journal of Neural Transmission. 62: 171-207. PMID 2863323 DOI: 10.1007/Bf01252236 |
0.658 |
|
| 1985 |
Gradin K, Pettersson A, Hjorth S, Hedner T, Arvidsson LE, Persson B. Cardiovascular effects in the Sprague-Dawley rat of 8-hydroxy-2(di-N-propylamino) tetralin, a selective 5-hydroxytryptamine receptor agonist. The Journal of Pharmacy and Pharmacology. 37: 263-5. PMID 2860226 |
0.402 |
|
| 1985 |
Hjorth S, Clark D, Carlsson A. Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations. Life Sciences. 37: 673-84. PMID 2410756 DOI: 10.1016/0024-3205(85)90435-7 |
0.695 |
|
| 1985 |
Johansson AM, Arvidsson L-, Hacksell U, Nilsson JLG, Svensson K, Hjorth S, Clark D, Carlsson A, Sanchez D, Andersson B, Wikstroem H. Novel Dopamine Receptor Agonists And Antagonists With Preferential Action On Autoreceptors Cheminform. 16. DOI: 10.1002/Chin.198548162 |
0.663 |
|
| 1985 |
Wikstroem H, Andersson B, Sanchez D, Lindberg P, Arvidsson L-, Johansson AM, Nilsson JLG, Svensson K, Hjorth S, Carlsson A. Resolved Monophenolic 2-Aminotetralins And 1,2,3,4,4A,5,6,10B-Octahydrobenzo(F)Quinolines: Structural And Stereochemical Considerations For Centrally Acting Pre- And Postsynaptic Dopamine-Receptor Agonists Cheminform. 16. DOI: 10.1002/Chin.198524182 |
0.579 |
|
| 1985 |
Wikstroem H, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-, Johansson AM, Thorberg S-, Nilsson JLG, Svensson K, Hjorth S, Clark D, Carlsson A. Resolved 3-(3-Hydroxyphenyl)-N-N-Propylpiperidine And Its Analogs: Central Dopamine Receptor Activity Cheminform. 16. DOI: 10.1002/Chin.198503222 |
0.597 |
|
| 1985 |
Hacksell U, Johansson AM, Arvidsson L-, Nilsson JLG, Hjorth S, Carlsson A, Wikstroem H, Sanchez D, Lindberg P. C1-Methylated 5-Hydroxy-2-(Dipropylamino)Tetralins: Central Dopamine-Receptor Stimulating Activity Cheminform. 16. DOI: 10.1002/Chin.198503183 |
0.605 |
|
| 1984 |
Hacksell U, Johansson AM, Arvidsson L, Nilsson JL, Hjorth S, Carlsson A, Wikström H, Sanchez D, Lindberg P. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity. Journal of Medicinal Chemistry. 27: 1003-7. PMID 6431102 DOI: 10.1021/Jm00374A012 |
0.669 |
|
| 1984 |
Arvidsson LE, Hacksell U, Johansson AM, Nilsson JL, Lindberg P, Sanchez D, Wikström H, Svensson K, Hjorth S, Carlsson A. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists. Journal of Medicinal Chemistry. 27: 45-51. PMID 6418888 DOI: 10.1021/Jm00367A009 |
0.664 |
|
| 1984 |
Schorderet M, Hjorth S, Hacksell U. Differential effects of the enantiomers of 3-PPP on dopamine D1-receptors of isolated rabbit retina. Journal of Neural Transmission. 59: 1-7. PMID 6325591 |
0.409 |
|
| 1984 |
Engel JA, Hjorth S, Svensson K, Carlsson A, Liljequist S. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). European Journal of Pharmacology. 105: 365-8. PMID 6239785 DOI: 10.1016/0014-2999(84)90634-4 |
0.729 |
|
| 1984 |
Clark D, Hjorth S, Carlsson A. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis. European Journal of Pharmacology. 106: 185-9. PMID 6099268 DOI: 10.1016/0014-2999(84)90694-0 |
0.64 |
|
| 1984 |
Hjorth S, Neumeyer JL. Central monoaminergic effects of two aporphine analogues to the putative serotonin-receptor agonist, 8-hydroxy-2-di-n-propylaminotetralin. Neuropharmacology. 23: 1187-90. PMID 6097834 DOI: 10.1016/0028-3908(84)90237-5 |
0.459 |
|
| 1984 |
Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson AM, Thorberg SO, Nilsson JL, Svensson K, Hjorth S. Resolved 3-(3-hydroxyphenyl)-N-n-propylpiperidine and its analogues: central dopamine receptor activity. Journal of Medicinal Chemistry. 27: 1030-6. PMID 6086923 |
0.405 |
|
| 1984 |
Arvidsson L-, Hacksell U, Johansson AM, Nilsson JLG, Lindberg P, Sanchez D, Wikstroem H, Svensson K, Hjorth S, Carlsson A. 8-Hydroxy-2-(Alkylamino)Tetralins And Related Compounds As Central 5-Hydroxytryptamine Receptor Agonists Cheminform. 15. DOI: 10.1002/Chin.198424168 |
0.584 |
|
| 1983 |
Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson A, Nilsson JL. The search for selective dopaminergic autoreceptor agonists. Journal of Neural Transmission. Supplementum. 18: 131-7. PMID 6576112 |
0.482 |
|
| 1983 |
Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson A. Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Psychopharmacology. 81: 89-99. PMID 6415751 DOI: 10.1007/BF00428999 |
0.63 |
|
| 1983 |
Clark D, Carlsson A, Hjorth S, Engel J, Lindberg P. The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat. Psychopharmacology. 81: 14-7. PMID 6138790 DOI: 10.1007/BF00439266 |
0.741 |
|
| 1983 |
Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-, Johansson A, Nilsson JLG. The search for selective dopaminergic autoreceptor agonists. Journal of Neural Transmission-Supplement. 18: 131-137. DOI: 10.1007/978-3-7091-4408-4_12 |
0.661 |
|
| 1983 |
Wikstroem H, Sanchez D, Lindberg P, Arvidsson L-, Hacksell U, Johansson A, Nilsson JLG, Hjorth S, Carlsson A. Monophenolic Octahydrobenzo(F)Quinolines: Central Dopamine- And Serotonin-Receptor Stimulating Activity Cheminform. 14. DOI: 10.1002/Chin.198303246 |
0.624 |
|
| 1982 |
Wikström H, Sanchez D, Lindberg P, Arvidsson LE, Hacksell U, Johansson A, Nilsson JL, Hjorth S, Carlsson A. Monophenolic octahydrobenzo[f]quinolines: central dopamine- and serotonin-receptor stimulating activity. Journal of Medicinal Chemistry. 25: 925-31. PMID 6811743 |
0.388 |
|
| 1982 |
Jackson D, Carlsson A, Hjorth S, Lindberg P. A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine). Journal of Neural Transmission. 53: 233-45. PMID 6286867 DOI: 10.1007/Bf01252035 |
0.612 |
|
| 1982 |
Hjorth S, Carlsson A. Buspirone: effects on central monoaminergic transmission--possible relevance to animal experimental and clinical findings. European Journal of Pharmacology. 83: 299-303. PMID 6129148 DOI: 10.1016/0014-2999(82)90265-5 |
0.652 |
|
| 1982 |
Clark D, Carlsson A, Hjorth S, Svensson K, Engel J, Sanchez D. Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioral studies. European Journal of Pharmacology. 83: 131-4. PMID 6127226 DOI: 10.1016/0014-2999(82)90297-7 |
0.696 |
|
| 1982 |
Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikström H, Arvidsson LE, Hacksell U, Nilsson JLG. 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity Journal of Neural Transmission. 55: 169-188. DOI: 10.1007/Bf01276574 |
0.651 |
|
| 1982 |
Hacksell U, Arvidsson L-, Svensson U, Nilsson JLG, Sanchez D, Wikstroem H, Lindberg P, Hjorth S, Carlsson A. 3-Phenylpiperidines. Central Dopamine-Autoreceptor Stimulating Activity Cheminform. 13. DOI: 10.1002/Chin.198222234 |
0.577 |
|
| 1982 |
Arvidsson L-, Hacksell U, Nilsson JLG, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstroem H. 8-Hydroxy-2-(Dipropylamino)Tetralin, A New Centrally Acting 5-Hydroxytryptamine Receptor Agonist Cheminform. 13. DOI: 10.1002/Chin.198203137 |
0.606 |
|
| 1981 |
Hacksell U, Arvidsson LE, Svensson U, Nilsson JL, Wikström H, Lindberg P, Sanchez D, Hjorth S, Carlsson A, Paalzow L. Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activity. Journal of Medicinal Chemistry. 24: 429-34. PMID 7265130 DOI: 10.1021/Jm00136A012 |
0.637 |
|
| 1981 |
Arvidsson LE, Hacksell U, Nilsson JL, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstrom H. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. Journal of Medicinal Chemistry. 24: 921-3. PMID 6460101 DOI: 10.1021/Jm00140A002 |
0.6 |
|
| 1981 |
Ahlenius S, Larsson K, Svensson L, Hjorth S, Carlsson A, Lindberg P, Wikström H, Sanchez D, Arvidsson LE, Hacksell U, Nilsson JL. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacology, Biochemistry, and Behavior. 15: 785-92. PMID 6458826 DOI: 10.1016/0091-3057(81)90023-X |
0.577 |
|
| 1981 |
Hjorth S, Carlsson A, Wikström H, Lindberg P, Sanchez D, Hacksell U, Arvidsson LE, Svensson U, Nilsson JL. 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors. Life Sciences. 28: 1225-38. PMID 6112651 DOI: 10.1016/0024-3205(81)90448-3 |
0.683 |
|
| 1981 |
Hacksell U, Arvidsson L-, Svensson U, Nilsson JLG, Wikstroem H, Lindberg P, Sanchez D, Hjorth S, Carlsson A, Paalzow L. Monophenolic 2-(Dipropylamino)Indans And Related Compounds: Central Dopamine-Receptor Stimulating Activity Cheminform. 12. DOI: 10.1002/Chin.198134192 |
0.62 |
|
| 1980 |
Hjorth S, Carlsson A, Lindberg P. A new centrally acting DA-receptor agonist with selectivity for autoreceptors. Psychopharmacology Bulletin. 16: 85-90. PMID 7403415 |
0.422 |
|
| 1980 |
Hacksell U, Svensson U, Nilsson JLG, Hjorth S, Carlsson A, Wikstroem H, Lindberg P, Sanchez D. N-Alkylated 2-Aminotetralins: Central Dopamine-Receptor Stimulating Activity Cheminform. 11. DOI: 10.1002/Chin.198015191 |
0.628 |
|
| 1979 |
Hacksell U, Svensson U, Nilsson JL, Hjorth S, Carlsson A, Wikström H, Lindenberg P, Sanchez D. N-Alkylated 2-aminotetralins: central dopamine-receptor stimulating activity. Journal of Medicinal Chemistry. 22: 1469-75. PMID 317109 |
0.319 |
|
| 1979 |
Wikstroem H, Lindberg P, Martinson P, Hjorth S, Carlsson A, Hacksell U, Svensson U, Nilsson JLG. Pivaloyl Esters Of N,N‐Dialkylated Dopamine Congeners. Central Dopamine‐Receptor Stimulating Activity Cheminform. 10. DOI: 10.1002/Chin.197908144 |
0.574 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1997 |
Bergqvist PBF, Hjorth S, Apelqvist G, Bengtsson F. Potassium-evoked neuronal release of serotonin in experimental chronic hepatic encephalopathy Biological Psychiatry. 42: 106. DOI: 10.1016/S0006-3223(97)87324-6 |
0.3 |
|
| 2016 |
Bjursell M, Ryberg E, Wu T, Greasley PJ, Bohlooly-Y M, Hjorth S. Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation. Plos One. 11: e0167965. PMID 27941994 DOI: 10.1371/journal.pone.0167965 |
0.29 |
|
| 1994 |
Schambye HT, von Wijk B, Hjorth SA, Wienen W, Entzeroth M, Bergsma DJ, Schwartz TW. Mutations in transmembrane segment VII of the AT1 receptor differentiate between closely related insurmountable and competitive angiotensin antagonists. British Journal of Pharmacology. 113: 331-3. PMID 7834178 |
0.288 |
|
| 1998 |
Hjorth SA, Orskov C, Schwartz TW. Constitutive activity of glucagon receptor mutants. Molecular Endocrinology (Baltimore, Md.). 12: 78-86. PMID 9440812 DOI: 10.1210/mend.12.1.0045 |
0.287 |
|
| 1981 |
Hacksell U, Arvidsson LE, Svensson U, Nilsson JL, Sanchez D, Wikström H, Lindberg P, Hjorth S, Carlsson A. 3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activity. Journal of Medicinal Chemistry. 24: 1475-82. PMID 6796690 |
0.285 |
|
| 1997 |
Schwartz TW, Perlman S, Rosenkilde MM, Hjorth SA. How receptor mutagenesis may confirm or confuse receptor classification. Annals of the New York Academy of Sciences. 812: 71-84. PMID 9186722 DOI: 10.1111/j.1749-6632.1997.tb48147.x |
0.282 |
|
| 1982 |
Hjorth S, Jackson D, Carlsson A, Lindberg P. A behavioral study of the changes in the CNS of mice after subchronic treatment with the dopamine autoreceptor agonist 3-PPP. Psychopharmacology Bulletin. 18: 149-52. PMID 7156279 |
0.28 |
|
| 2000 |
Nielsen SM, Nielsen LZ, Hjorth SA, Perrin MH, Vale WW. Constitutive activation of tethered-peptide/corticotropin-releasing factor receptor chimeras. Proceedings of the National Academy of Sciences of the United States of America. 97: 10277-81. PMID 10963687 |
0.279 |
|
| 2000 |
Larson DL, Jones RM, Hjorth SA, Schwartz TW, Portoghese PS. Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonists. Journal of Medicinal Chemistry. 43: 1573-6. PMID 10780914 DOI: 10.1021/Jm000059G |
0.272 |
|
| 2015 |
Gabrielsson J, Hjorth S, Vogg B, Harlfinger S, Gutierrez PM, Peletier L, Pehrson R, Davidsson P. Modeling and design of challenge tests: Inflammatory and metabolic biomarker study examples. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 67: 144-59. PMID 25435491 DOI: 10.1016/J.Ejps.2014.11.006 |
0.271 |
|
| 2009 |
Lindström E, Ravnefjord A, Brusberg M, Hjorth S, Larsson H, Martinez V. The selective 5-hydroxytryptamine 1A antagonist, AZD7371 [3(R)-(N,N-dicyclobutylamino)-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide (R,R)-tartrate monohydrate] (robalzotan tartrate monohydrate), inhibits visceral pain-related visceromotor, but not autonomic cardiovascular, responses to colorectal distension in rats. The Journal of Pharmacology and Experimental Therapeutics. 329: 1048-55. PMID 19325032 DOI: 10.1124/jpet.109.152330 |
0.271 |
|
| 1997 |
Bergqvist PBF, Hjorth S, Wikell C, Apelqvist G, Bengtsson F. P.1.173 In vivo studies on the brain serotonin output in experimental chronic hepatic encephalopathy European Neuropsychopharmacology. 7. DOI: 10.1016/S0924-977X(97)88622-1 |
0.27 |
|
| 1995 |
Perlman S, Schambye HT, Rivero RA, Greenlee WJ, Hjorth SA, Schwartz TW. Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor. The Journal of Biological Chemistry. 270: 1493-6. PMID 7829475 DOI: 10.1074/JBC.270.4.1493 |
0.269 |
|
| 1996 |
Hjorth SA, Thirstrup K, Schwartz TW. Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor. Molecular Pharmacology. 50: 977-84. PMID 8863844 |
0.266 |
|
| 1996 |
Hjorth SA, Schwartz TW. Glucagon and GLP-1 receptors: lessons from chimeric ligands and receptors. Acta Physiologica Scandinavica. 157: 343-5. PMID 8830889 DOI: 10.1046/j.1365-201X.1996.37259000.x |
0.264 |
|
| 1978 |
Wikström H, Lindberg P, Martinson P, Hjorth S, Carlsson A. Pivaloyl esters of N,N-dialkylated dopamine congeners. Central dopamine-receptor stimulating activity. Journal of Medicinal Chemistry. 21: 864-7. PMID 722753 |
0.26 |
|
| 2007 |
Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ. The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology. 152: 1092-101. PMID 17876302 DOI: 10.1038/sj.bjp.0707460 |
0.26 |
|
| 2019 |
Gabrielsson J, Andersson R, Jirstrand M, Hjorth S. Dose-Response-Time Data Analysis: An Underexploited Trinity. Pharmacological Reviews. 71: 89-122. PMID 30587536 DOI: 10.1124/pr.118.015750 |
0.258 |
|
| 2002 |
Wikell C, Apelqvist G, Hjorth S, Kullingsjö J, Bergqvist PB, Bengtsson F. Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 12: 327-36. PMID 12126872 DOI: 10.1016/S0924-977X(02)00044-5 |
0.258 |
|
| 2015 |
Gennemark P, Hjorth S, Gabrielsson J. Modeling energy intake by adding homeostatic feedback and drug intervention. Journal of Pharmacokinetics and Pharmacodynamics. 42: 79-96. PMID 25388764 DOI: 10.1007/s10928-014-9399-4 |
0.25 |
|
| 2018 |
Gabrielsson J, Peletier LA, Hjorth S. Lost in translation: What's in an EC? Innovative PK/PD reasoning in the drug development context. European Journal of Pharmacology. PMID 30036536 DOI: 10.1016/J.Ejphar.2018.07.037 |
0.249 |
|
| 2015 |
Gabrielsson J, Hjorth S. Pattern Recognition in Pharmacodynamic Data Analysis. The Aaps Journal. PMID 26542613 DOI: 10.1208/s12248-015-9842-5 |
0.248 |
|
| 1998 |
Wikell C, Bergqvist PB, Hjorth S, Apelqvist G, Björk H, Bengtsson F. Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathy. Clinical Neuropharmacology. 21: 296-306. PMID 9789710 |
0.243 |
|
| 1995 |
Hjorth SA, Thirstrup K, Grandy DK, Schwartz TW. Analysis of selective binding epitopes for the kappa-opioid receptor antagonist nor-binaltorphimine. Molecular Pharmacology. 47: 1089-94. PMID 7541509 |
0.241 |
|
| 2002 |
Costa-Neto CM, Miyakawa AA, Pesquero JB, Oliveira L, Hjorth SA, Schwartz TW, Paiva AC. Interaction of a non-peptide agonist with angiotensin II AT1 receptor mutants. Canadian Journal of Physiology and Pharmacology. 80: 413-7. PMID 12056547 DOI: 10.1139/y02-058 |
0.239 |
|
| 1995 |
Schambye HT, Hjorth SA, Weinstock J, Schwartz TW. Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor. Molecular Pharmacology. 47: 425-31. PMID 7700239 |
0.236 |
|
| 1997 |
Perlman S, Costa-Neto CM, Miyakawa AA, Schambye HT, Hjorth SA, Paiva AC, Rivero RA, Greenlee WJ, Schwartz TW. Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands: susceptibility to receptor mutations. Molecular Pharmacology. 51: 301-11. PMID 9203636 |
0.233 |
|
| 1994 |
Hjorth SA, Adelhorst K, Pedersen BB, Kirk O, Schwartz TW. Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes. The Journal of Biological Chemistry. 269: 30121-4. PMID 7527026 |
0.233 |
|
| 2017 |
Gabrielsson J, Peletier LA, Hjorth S. In vivo potency revisited - Keep the target inl sight. Pharmacology & Therapeutics. PMID 29024741 DOI: 10.1016/J.Pharmthera.2017.10.011 |
0.23 |
|
| 1994 |
Schambye HT, Hjorth SA, Bergsma DJ, Sathe G, Schwartz TW. Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors. Proceedings of the National Academy of Sciences of the United States of America. 91: 7046-50. PMID 8041743 DOI: 10.1073/pnas.91.15.7046 |
0.224 |
|
| 1997 |
Bergqvist PBF, Wikell C, Hjorth S, Apelqvist G, Bengtsson F. P.1.016 Effects of a single venlafaxine challenge on the neocortical monoamine output in experimental chronic hepatic encephalopathy European Neuropsychopharmacology. 7. DOI: 10.1016/S0924-977X(97)88466-0 |
0.22 |
|
| 1999 |
Wikell C, Apelqvist G, Carlsson B, Hjorth S, Bergqvist PB, Kugelberg FC, Ahlner J, Bengtsson F. Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats. Clinical Neuropharmacology. 22: 327-36. PMID 10626092 |
0.218 |
|
| 2004 |
Bohlooly-Y M, Mahlapuu M, Andersén H, Astrand A, Hjorth S, Svensson L, Törnell J, Snaith MR, Morgan DG, Ohlsson C. Osteoporosis in MCHR1-deficient mice. Biochemical and Biophysical Research Communications. 318: 964-9. PMID 15147966 DOI: 10.1016/j.bbrc.2004.04.122 |
0.218 |
|
| 1993 |
Schambye HT, Hjorth SA, Schwartz TW. [Non-peptide antagonists to angiotensin II receptors. A review]. Ugeskrift For Laeger. 155: 3558-62. PMID 8236577 |
0.215 |
|
| 2017 |
Morabito MV, Ravussin Y, Mueller BR, Skowronski AA, Watanabe K, Foo KS, Lee SX, Lehmann A, Hjorth S, Zeltser LM, LeDuc CA, Leibel RL. Weight Perturbation Alters Leptin Signal Transduction in a Region-Specific Manner throughout the Brain. Plos One. 12: e0168226. PMID 28107353 DOI: 10.1371/Journal.Pone.0168226 |
0.213 |
|
| 2018 |
Carlsson LMS, Sjöholm K, Ahlin S, Jacobson P, Andersson-Assarsson JC, Karlsson Lindahl L, Maglio C, Karlsson C, Hjorth S, Taube M, Carlsson B, Svensson PA, Peltonen M. Long-term incidence of serious fall-related injuries after bariatric surgery in Swedish obese subjects. International Journal of Obesity (2005). PMID 29795467 DOI: 10.1038/s41366-018-0097-y |
0.213 |
|
| 1998 |
Peilot H, Bengtsson HJ, Hjorth S. Regional differences in autoreceptor control of 5-hydroxytryptamine release in the rat central nervous system in vivo? Nordic Journal of Psychiatry. 52: 128. |
0.21 |
|
| 1996 |
Thirstrup K, Elling CE, Hjorth SA, Schwartz TW. Construction of a high affinity zinc switch in the kappa-opioid receptor. The Journal of Biological Chemistry. 271: 7875-8. PMID 8626461 DOI: 10.1074/jbc.271.14.7875 |
0.199 |
|
| 2000 |
Hjorth S, Hutson PH. Introduction — Neuroregulation of serotoninergic systems: basic and clinical perspectives Journal of Psychopharmacology. 14: 99-99. DOI: 10.1177/026988110001400215 |
0.194 |
|
| 1998 |
Holst B, Zoffmann S, Elling CE, Hjorth SA, Schwartz TW. Steric hindrance mutagenesis versus alanine scan in mapping of ligand binding sites in the tachykinin NK1 receptor. Molecular Pharmacology. 53: 166-75. PMID 9443945 |
0.19 |
|
| 1997 |
Elling CE, Thirstrup K, Nielsen SM, Hjorth SA, Schwartz TW. Engineering of metal-ion sites as distance constraints in structural and functional analysis of 7TM receptors. Folding & Design. 2: S76-80. PMID 9269573 |
0.187 |
|
| 1993 |
Hansen BS, Hjorth S, Welinder BS, Skriver L, De Meyts P. The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells. Endocrinology. 133: 2809-17. PMID 8243308 DOI: 10.1210/endo.133.6.8243308 |
0.186 |
|
| 1985 |
Hjorth S. Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT. Journal of Neural Transmission. 61: 131-5. PMID 3156965 |
0.186 |
|
| 2017 |
Carlsson LM, Sjöholm K, Karlsson C, Jacobson P, Andersson-Assarsson JC, Svensson PA, Larsson I, Hjorth S, Neovius M, Taube M, Carlsson B, Peltonen M. Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study. The Lancet. Diabetes & Endocrinology. PMID 28237791 DOI: 10.1016/S2213-8587(17)30061-X |
0.183 |
|
| 1994 |
Schwartz TW, Hjorth SA, Elling C, Nielsen SM, Gether U, Rosenkilde MM, Zoffmann S, den Hollander R, Schambye HT, Perlmann S, van Vijk B. Molecular mechanism of activation and inhibition of 7TM peptide receptors European Journal of Pharmaceutical Sciences. 2: 85-87. DOI: 10.1016/0928-0987(94)90081-7 |
0.182 |
|
| 2024 |
Stan TL, Ronaghi A, Barrientos SA, Halje P, Censoni L, Garro-Martínez E, Nasretdinov A, Malinina E, Hjorth S, Svensson P, Waters S, Sahlholm K, Petersson P. Neurophysiological treatment effects of mesdopetam, pimavanserin and clozapine in a rodent model of Parkinson's disease psychosis. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. e00334. PMID 38368170 DOI: 10.1016/j.neurot.2024.e00334 |
0.18 |
|
| 2021 |
Hjorth S. The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective. Frontiers in Psychiatry. 12: 760181. PMID 34899422 DOI: 10.3389/fpsyt.2021.760181 |
0.178 |
|
| 2019 |
Hjorth S, Näslund I, Andersson-Assarsson JC, Svensson PA, Jacobson P, Peltonen M, Carlsson LMS. Reoperations After Bariatric Surgery in 26 Years of Follow-up of the Swedish Obese Subjects Study. Jama Surgery. PMID 30601881 DOI: 10.1001/jamasurg.2018.5084 |
0.175 |
|
| 1994 |
Rosenkilde MM, Cahir M, Gether U, Hjorth SA, Schwartz TW. Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. The Journal of Biological Chemistry. 269: 28160-4. PMID 7525569 |
0.17 |
|
| 2000 |
Costa-Neto CM, Miyakawa AA, Oliveira L, Hjorth SA, Schwartz TW, Paiva AC. Mutational analysis of the interaction of the N- and C-terminal ends of angiotensin II with the rat AT(1A) receptor. British Journal of Pharmacology. 130: 1263-8. PMID 10903964 DOI: 10.1038/sj.bjp.0703430 |
0.169 |
|
| 2019 |
Näslund I, Hjorth S, Carlsson LMS. Revisions of Gastric Bypass-A Moral Obligation-Reply. Jama Surgery. PMID 31215984 DOI: 10.1001/jamasurg.2019.1741 |
0.169 |
|
| 2015 |
Read CB, Kuijper JL, Hjorth SA, Heipel MD, Tang X, Fleetwood AJ, Dantzler JL, Grell SN, Kastrup J, Wang C, Brandt CS, Hansen AJ, Wagtmann NR, Xu W, Stennicke VW. Cutting Edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1. Journal of Immunology (Baltimore, Md. : 1950). 194: 1417-21. PMID 25595774 DOI: 10.4049/jimmunol.1402303 |
0.162 |
|
| 1998 |
Jones RM, Hjorth SA, Schwartz TW, Portoghese PS. Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors. Journal of Medicinal Chemistry. 41: 4911-4. PMID 9836606 DOI: 10.1021/Jm9805182 |
0.158 |
|
| 1994 |
Hjorth SA, Schambye HT, Greenlee WJ, Schwartz TW. Identification of peptide binding residues in the extracellular domains of the AT1 receptor. The Journal of Biological Chemistry. 269: 30953-9. PMID 7983030 |
0.155 |
|
| 1993 |
Hjorth S, Brogård B, Christensen LB, Adelhorst K, Kirk O, Schwartz T. GLP-1 and glucagon: Homologous peptides interacting with homologous receptors Digestion. 54: 343. DOI: 10.1159/000201055 |
0.154 |
|
| 1985 |
Hacksell U, Arvidsson LE, Johansson AM, Nilsson JL, Sanchez D, Andersson B, Lindberg P, Wikström H, Hjorth S, Svensson K. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects. Acta Pharmaceutica Suecica. 22: 65-74. PMID 2996294 |
0.152 |
|
| 1983 |
Hjorth S. On the mode of action of 3-(3-hydroxyphenyl)-N-n-propylpiperidine, 3-PPP, and its enantiomers. With particular reference to dopaminergic mechanisms in the central nervous system. Acta Physiologica Scandinavica. Supplementum. 517: 1-52. PMID 6138921 |
0.145 |
|
| 1986 |
Hacksell U, Arvidsson LE, Johansson AM, Nilsson JL, Sanchez D, Lindberg P, Wikström H, Svensson K, Hjorth S, Carlsson A. Indirect central 5-hydroxytryptaminergic actions of methoxy substituted 2-aminotetralin derivatives. Acta Pharmaceutica Suecica. 23: 77-90. PMID 3739739 |
0.137 |
|
| 1997 |
Greenwood MT, Hukovic N, Kumar U, Panetta R, Hjorth SA, Srikant CB, Patel YC. Ligand binding pocket of the human somatostatin receptor 5: mutational analysis of the extracellular domains. Molecular Pharmacology. 52: 807-14. PMID 9351971 |
0.133 |
|
| 2012 |
Hamming OJ, Kang L, Svensson A, Karlsen JL, Rahbek-Nielsen H, Paludan SR, Hjorth SA, Bondensgaard K, Hartmann R. Crystal structure of interleukin-21 receptor (IL-21R) bound to IL-21 reveals that sugar chain interacting with WSXWS motif is integral part of IL-21R. The Journal of Biological Chemistry. 287: 9454-60. PMID 22235133 DOI: 10.1074/jbc.M111.311084 |
0.132 |
|
| 2012 |
Kallenbach K, Hjorth SV, Engel U, Schlesinger NH, Holck S. Significance of acquired diverticular disease of the vermiform appendix: a marker of regional neoplasms? Journal of Clinical Pathology. 65: 638-42. PMID 22461655 DOI: 10.1136/jclinpath-2011-200647 |
0.124 |
|
| 1997 |
Elling CE, Thirstrup K, Nielsen SM, Hjorth SA, Schwartz TW. Metal-ion sites as structural and functional probes of helix-helix interactions in 7TM receptors. Annals of the New York Academy of Sciences. 814: 142-51. PMID 9160966 DOI: 10.1111/j.1749-6632.1997.tb46152.x |
0.123 |
|
| 1995 |
Schwartz TW, Gether U, Schambye HT, Hjorth SA. Molecular mechanism of action of non-peptide ligands for peptide receptors Current Pharmaceutical Design. 1: 325-342. |
0.111 |
|
| 2007 |
Bondensgaard K, Breinholt J, Madsen D, Omkvist DH, Kang L, Worsaae A, Becker P, Schiødt CB, Hjorth SA. The existence of multiple conformers of interleukin-21 directs engineering of a superpotent analogue. The Journal of Biological Chemistry. 282: 23326-36. PMID 17565991 DOI: 10.1074/jbc.M701313200 |
0.105 |
|
| 2023 |
Gabrielsson J, Hjorth S. Turn on, tune in, turnover! Target biology impacts in vivo potency, efficacy, and clearance. Pharmacological Reviews. PMID 36627211 DOI: 10.1124/pharmrev.121.000524 |
0.098 |
|
| 2022 |
Bogren M, Soltesz M, Hjorth S. Remission of Persistent Negative Symptoms and Psychosocial Consequences by Combined Clozapine and Cariprazine Treatment in a Patient With Long-Standing Treatment-Resistant Schizoaffective Disorder. Frontiers in Psychiatry. 13: 887547. PMID 35664491 DOI: 10.3389/fpsyt.2022.887547 |
0.089 |
|
| 2004 |
Ørskov C, Hjorth SA, Jensen AD, Vilsbøll T. Typical Danish Caucasian type 2 diabetic patients do not commonly carry genetic variants in GIP and GLP-1 encoding regions of the proGIP and proglucagon genes. Regulatory Peptides. 119: 151-4. PMID 15120474 DOI: 10.1016/j.regpep.2004.03.007 |
0.075 |
|
| 1998 |
Wikell C, Bergqvist PBF, Apelqvist G, Hjorth S, Bengtsson F. Venlafaxine challenge alters the brain monoamine output in experimental hepatic encephalopathy[linkI] Nordic Journal of Psychiatry. 52: 124. |
0.075 |
|
| 1993 |
Thirstrup K, Carrière F, Hjorth S, Rasmussen PB, Wöldike H, Nielsen PF, Thim L. One-step purification and characterization of human pancreatic lipase expressed in insect cells. Febs Letters. 327: 79-84. PMID 8335100 DOI: 10.1016/0014-5793(93)81044-Z |
0.074 |
|
| 2021 |
Rodriguez Cruz J, Sahlsten Schölin J, Hjorth S. Case Report: Cariprazine in a Patient With Schizophrenia, Substance Abuse, and Cognitive Dysfunction. Frontiers in Psychiatry. 12: 727666. PMID 34489766 DOI: 10.3389/fpsyt.2021.727666 |
0.073 |
|
| 2023 |
Sahlsten Schölin J, Rodriguez Cruz J, Hjorth S. Successful switching from risperidone to cariprazine in a schizophrenic patient with pronounced functional deficit. Case report. Frontiers in Psychiatry. 14: 1155395. PMID 37020736 DOI: 10.3389/fpsyt.2023.1155395 |
0.072 |
|
| 1997 |
Carrière F, Thirstrup K, Hjorth S, Ferrato F, Nielsen PF, Withers-Martinez C, Cambillau C, Boel E, Thim L, Verger R. Pancreatic lipase structure-function relationships by domain exchange. Biochemistry. 36: 239-48. PMID 8993339 DOI: 10.1021/Bi961991P |
0.07 |
|
| 1995 |
Thirstrup K, Carrière F, Hjorth SA, Rasmussen PB, Nielsen PF, Ladefoged C, Thim L, Boel E. Cloning and expression in insect cells of two pancreatic lipases and a procolipase from Myocastor coypus. European Journal of Biochemistry / Febs. 227: 186-93. PMID 7851384 DOI: 10.1111/j.1432-1033.1995.tb20375.x |
0.067 |
|
| 2010 |
Kang L, Bondensgaard K, Li T, Hartmann R, Hjorth SA. Rational design of interleukin-21 antagonist through selective elimination of the gammaC binding epitope. The Journal of Biological Chemistry. 285: 12223-31. PMID 20167599 DOI: 10.1074/jbc.M110.101444 |
0.052 |
|
| 1985 |
Kafi-de St Hilaire S, Sovilla JY, Hjorth S, Gaillard JM. Modifications of sleep parameters in the rat by (+)- and (-)-3-PPP. Journal of Neural Transmission. 62: 209-17. PMID 4031842 |
0.051 |
|
| 2000 |
Hjorth S, Hutson PH. European Winter Conference on Brain Research, Plagne Lauzes, France, 6-13 March 1999. Introduction - Neuroregulation of serotoninergic systems: Basic and clinical perspectives Journal of Psychopharmacology. 14: 99. |
0.043 |
|
| 1950 |
ENGSTROM H, HJORTH S. On the distribution and localization of injected dyes in the labyrinth of the guinea-pig. Acta Oto-Laryngologica. Supplementum. 95: 149-58. PMID 14884977 |
0.043 |
|
| 1994 |
Carrière F, Thirstrup K, Hjorth S, Boel E. Cloning of the classical guinea pig pancreatic lipase and comparison with the lipase related protein 2. Febs Letters. 338: 63-8. PMID 8307159 DOI: 10.1016/0014-5793(94)80117-7 |
0.036 |
|
| 2006 |
Hjorth SV, Björnelius E, Lidbrink P, Falk L, Dohn B, Berthelsen L, Ma L, Martin DH, Jensen JS. Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. Journal of Clinical Microbiology. 44: 2078-83. PMID 16757601 DOI: 10.1128/JCM.00003-06 |
0.033 |
|
| 2005 |
Fjeldsøe-Nielsen H, Unemo M, Fredlund H, Hjorth SV, Berthelsen LM, Palmer HM, Friis-Møller A. Phenotypic and genotypic characterization of prolyliminopeptidase-negative Neisseria gonorrhoeae isolates in Denmark. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 24: 280-3. PMID 15902536 DOI: 10.1007/s10096-005-1319-5 |
0.031 |
|
| 1998 |
Amanullah A, Hjorth SA, Nienow AW. A new mathematical model to predict cavern diameters in highly shear thinning, power law liquids using axial flow impellers Chemical Engineering Science. 53: 455-469. DOI: 10.1016/S0009-2509(97)00200-5 |
0.026 |
|
| 1997 |
Amanullah A, Hjorth SA, Nienow AW. Cavern sizes generated in highly shear thinning viscous fluids by SCABA 3SHP1 impellers Food and Bioproducts Processing: Transactions of the Institution of of Chemical Engineers, Part C. 75: 232-238. |
0.026 |
|
| 2010 |
Bondensgaard K, Kang L, Hjorth SA. IL-21 increased potency design Handbook of Cell Signaling, 2/E. 1: 315-322. DOI: 10.1016/B978-0-12-374145-5.00046-2 |
0.025 |
|
| 1954 |
WERSALL J, ENGSTROM H, HJORTH S. Fine structure of the guinea-pig macula utriculi; a preliminary report. Acta Oto-Laryngologica. Supplementum. 116: 298-303. PMID 13188694 |
0.024 |
|
| 2023 |
Sjöholm K, Andersson-Assarsson JC, Kristensson FM, Hjorth S, Garelius HG, Jacobson P, Svensson PA, Ahlin S, Carlsson B, Peltonen M, Carlsson LMS, Taube M. Long-term incidence of haematological cancer after bariatric surgery or usual care in the Swedish Obese Subjects study: a prospective cohort study. The Lancet. Healthy Longevity. PMID 37716360 DOI: 10.1016/S2666-7568(23)00141-1 |
0.021 |
|
| 2003 |
Hoeks FW, Boon LA, Studer F, Wolff MO, van der Schot F, Vrabél P, van der Lans RG, Bujalski W, Manelius A, Blomsten G, Hjorth S, Prada G, Luyben KCh, Nienow AW. Scale-up of stirring as foam disruption (SAFD) to industrial scale. Journal of Industrial Microbiology & Biotechnology. 30: 118-28. PMID 12612787 DOI: 10.1007/s10295-003-0023-7 |
0.017 |
|
| 1959 |
HJORTH S, LUNDBORG T, ROSLER G. [On sound conduction mechanism of the middle ear. An anatomical and practical clinical study in normal cases and in various pathological variations]. Acta Oto-Laryngologica. 50: 423-37. PMID 14402081 |
0.016 |
|
| 2010 |
Hjorth SV, Vainer B, Petersen BL, Larsen FS, Hasle H. Acute lymphoblastic leukemia with Philadelphia chromosome in a 39-year-old woman with Down syndrome presenting as meningitis and fulminant liver failure. Leukemia Research. 34: e297-9. PMID 20598743 DOI: 10.1016/j.leukres.2010.06.007 |
0.015 |
|
| 1977 |
Hjorth S, Magnusson PH, Blomquist P. Adenoid cystic carcinoma of the breast. Report of a case in a male and review of the literature. Acta Chirurgica Scandinavica. 143: 155-8. PMID 200041 |
0.013 |
|
| 1977 |
Berjljung L, Hjorth S, Svendler CA, Odén B. Angiography in acute gastrointestinal bleeding. Surgery, Gynecology & Obstetrics. 145: 501-3. PMID 302497 |
0.012 |
|
| 1953 |
CARLSTROM D, ENGSTROM H, HJORTH S. Electron microscopic and x-ray diffraction studies of statoconia. The Laryngoscope. 63: 1052-7. PMID 13110207 DOI: 10.1288/00005537-195311000-00002 |
0.01 |
|
| 1994 |
Kühle A, Skov JL, Hjorth S, Rasmussen I, Hansen JB. Smooth YBa2Cu3O7-x thin films prepared by pulsed laser deposition in O2/Ar atmosphere Applied Physics Letters. 64: 3178-3180. DOI: 10.1063/1.111331 |
0.01 |
|
| 2000 |
Hjorth S, Karlsson L, Friberg P, Boon L. An analysis of the use of electrical power measurements for process control in large-scale stirred vessels Canadian Journal of Chemical Engineering. 78: 1127-1132. |
0.01 |
|
| 1994 |
Bodin P, Skov JL, Kuhle A, Hagensen M, Clausen T, Rasmussen I, Hjorth S, Hansen JB. Double-sided YBa2Cu3O7-x thin films for microwave applications Superconductor Science and Technology. 7: 717-720. DOI: 10.1088/0953-2048/7/10/004 |
0.01 |
|
| 1955 |
HJORTH S. [Hearing and healing after tympanoplasty; case review]. Acta Oto-Laryngologica. 45: 458-65. PMID 13275313 |
0.01 |
|
| Hide low-probability matches. |